| COVID-19: consider cytokine storm syndromes and immunosuppression P Mehta, DF McAuley, M Brown, E Sanchez, RS Tattersall, JJ Manson The lancet 395 (10229), 1033-1034, 2020 | 11248 | 2020 |
| Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study RA Evans, OC Leavy, M Richardson, O Elneima, HJC McAuley, ... The Lancet Respiratory Medicine 10 (8), 761-775, 2022 | 286 | 2022 |
| COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study JJ Manson, C Crooks, M Naja, A Ledlie, B Goulden, T Liddle, E Khan, ... The Lancet Rheumatology 2 (10), e594-e602, 2020 | 267 | 2020 |
| Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome P Mehta, RQ Cron, J Hartwell, JJ Manson, RS Tattersall The Lancet Rheumatology 2 (6), e358-e367, 2020 | 258 | 2020 |
| Local and systemic responses to SARS-CoV-2 infection in children and adults M Yoshida, KB Worlock, N Huang, RGH Lindeboom, CR Butler, ... Nature 602 (7896), 321-327, 2022 | 227 | 2022 |
| The intersection of COVID-19 and autoimmunity JS Knight, R Caricchio, JL Casanova, AJ Combes, B Diamond, SE Fox, ... The Journal of clinical investigation 131 (24), 2021 | 174 | 2021 |
| Therapeutic blockade of granulocyte macrophage colony-stimulating factor in COVID-19-associated hyperinflammation: challenges and opportunities P Mehta, JC Porter, JJ Manson, JD Isaacs, PJM Openshaw, IB McInnes, ... The Lancet Respiratory Medicine 8 (8), 822-830, 2020 | 133 | 2020 |
| EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update RBM Landewé, FPB Kroon, A Alunno, A Najm, JWJ Bijlsma, ... Annals of the rheumatic diseases 81 (12), 1628-1639, 2022 | 132 | 2022 |
| In vivo kinetics of kinase domain mutations in CML patients treated with dasatinib after failing imatinib JS Khorashad, D Milojkovic, P Mehta, M Anand, S Ghorashian, AG Reid, ... Blood, The Journal of the American Society of Hematology 111 (4), 2378-2381, 2008 | 99 | 2008 |
| Is severe COVID-19 a cytokine storm syndrome: a hyperinflammatory debate P Mehta, DC Fajgenbaum Current opinion in Rheumatology 33 (5), 419-430, 2021 | 77 | 2021 |
| Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals M Heightman, J Prashar, TE Hillman, M Marks, R Livingston, HA Ridsdale, ... BMJ open respiratory research 8 (1), e001041, 2021 | 76 | 2021 |
| JAK inhibitors in COVID-19: the need for vigilance regarding increased inherent thrombotic risk P Mehta, C Ciurtin, M Scully, M Levi, RC Chambers European Respiratory Journal 56 (3), 2020 | 76 | 2020 |
| B-cell depletion with rituximab in the COVID-19 pandemic: where do we stand? P Mehta, JC Porter, RC Chambers, DA Isenberg, V Reddy The Lancet Rheumatology 2 (10), e589-e590, 2020 | 75 | 2020 |
| Is fibromyalgia associated with a unique cytokine profile? A systematic review and meta-analysis LF O’Mahony, A Srivastava, P Mehta, C Ciurtin Rheumatology 60 (6), 2602-2614, 2021 | 74 | 2021 |
| Across Speciality Collaboration UK. COVID-19: consider cytokine storm syndromes and immunosuppression P Mehta, DF McAuley, M Brown, E Sanchez, RS Tattersall, JJ Manson, ... Lancet 395 (10229), 1033-1034, 2020 | 68 | 2020 |
| SLE with C1q deficiency treated with fresh frozen plasma: a 10-year experience P Mehta, PJ Norsworthy, AE Hall, SJ Kelly, MJ Walport, M Botto, ... Rheumatology 49 (4), 823-824, 2010 | 65 | 2010 |
| Correspondence COVID-19: consider cytokine storm syndromes and P Mehta, DF Mcauley, M Brown, E Sanchez, RS Tattersall, JJ Manson, ... Lancet 6736 (20), 19-20, 2020 | 61 | 2020 |
| Residual lung abnormalities after COVID-19 hospitalization: interim analysis of the UKILD post–COVID-19 study I Stewart, J Jacob, PM George, PL Molyneaux, JC Porter, RJ Allen, ... American journal of respiratory and critical care medicine 207 (6), 693-703, 2023 | 60 | 2023 |
| SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination F Liew, S Talwar, A Cross, BJ Willett, S Scott, N Logan, MK Siggins, ... EBioMedicine 87, 2023 | 59 | 2023 |
| JJ MansonHLH across specialty collaboration, UK P Mehta, DF McAuley, M Brown, E Sanchez, RS Tattersall Covid-19: Consider Cytokine StormSyndromes and Immunosuppression Lancet …, 2020 | 58 | 2020 |
Joanna C PorterProfessor in Respiratory Medicine, UCL, LondonVerified email at ucl.ac.uk
